Astellas hires senior vice president for new Global Medical Affairs organisation

pharmafile | February 24, 2012 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing  

Astellas has announced that Charlotte Kremer has joined the company as the head of one of the Company’s newest organisations – Global Medical Affairs (GMA).

In this new role Kremer will provide global leadership for medical excellence and a unified medical perspective across regions for Astellas’ portfolio.

“We are thrilled to have Charlotte join Astellas. She brings years of experience and an outstanding reputation to this new, global leadership role,” said Yoshihiko Hatanaka, president and chief executive of Astellas.

Kremer comes to Astellas with 20 years’ experience in the pharmaceutical industry. Most recently, Kremer held the position of vice president, Therapeutic Area head for Ophthalmology, PVD, Rare Diseases and Neuroscience at Pfizer.

Advertisement

While at Pfizer, she successfully led and executed the clinical development and global medical strategy in these respective areas. Prior to joining Pfizer, Kremer held positions of increasing responsibility providing medical support, developing Phase IIIB/IV clinical trials, and initiating and directing a medical liaison program at Organon Pharmaceuticals, both in the Netherlands and in the US.

A native of the Netherlands, Kremer received her undergraduate and medical degrees from the University of Utrecht. She went on to receive her Diploma Pharmaceutical Medicine (DPM) from Universite Libre de Bruxelles. After transferring to the US, Kremer completed the Executive MBA program at New York University’s Leonard N. Stern School of Business.

Related Content

No items found
The Gateway to Local Adoption Series

Latest content